Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?

Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhashmi, Jasem Mohammed, Elhoufi, Ashraf M., Elhatou, Eman, Ghanaim, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802120/
http://dx.doi.org/10.1159/000509906
_version_ 1783635706746241024
author Alhashmi, Jasem Mohammed
Elhoufi, Ashraf M.
Elhatou, Eman
Ghanaim, Mahmood
author_facet Alhashmi, Jasem Mohammed
Elhoufi, Ashraf M.
Elhatou, Eman
Ghanaim, Mahmood
author_sort Alhashmi, Jasem Mohammed
collection PubMed
description Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He developed a right ventricular (RV) thrombus (rare condition) and multiple brain sites infarction. We discuss this phenomena by showing the extent to which the thrombosis can take place, the possible relation between inflammatory, D-dimer and case progression and suggest a treatment approach particularly in cases with multiple thrombogenicity organ involvement.
format Online
Article
Text
id pubmed-7802120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-78021202021-01-13 Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments? Alhashmi, Jasem Mohammed Elhoufi, Ashraf M. Elhatou, Eman Ghanaim, Mahmood Dubai Medical Journal Case Report Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He developed a right ventricular (RV) thrombus (rare condition) and multiple brain sites infarction. We discuss this phenomena by showing the extent to which the thrombosis can take place, the possible relation between inflammatory, D-dimer and case progression and suggest a treatment approach particularly in cases with multiple thrombogenicity organ involvement. S. Karger AG 2020-12-11 /pmc/articles/PMC7802120/ http://dx.doi.org/10.1159/000509906 Text en Copyright © 2020 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Case Report
Alhashmi, Jasem Mohammed
Elhoufi, Ashraf M.
Elhatou, Eman
Ghanaim, Mahmood
Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title_full Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title_fullStr Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title_full_unstemmed Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title_short Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?
title_sort disseminated thrombosis in covid-19 cases: the role of early antithrombotic treatments?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802120/
http://dx.doi.org/10.1159/000509906
work_keys_str_mv AT alhashmijasemmohammed disseminatedthrombosisincovid19casestheroleofearlyantithrombotictreatments
AT elhoufiashrafm disseminatedthrombosisincovid19casestheroleofearlyantithrombotictreatments
AT elhatoueman disseminatedthrombosisincovid19casestheroleofearlyantithrombotictreatments
AT ghanaimmahmood disseminatedthrombosisincovid19casestheroleofearlyantithrombotictreatments

Ejemplares similares